viral vector

The benefits of PiggyBac transposon-mediated CAR-T cell technology 2:37
The benefits of PiggyBac transposon-mediated CAR-T cell technology
Shigeki Yagyu • 8 Apr 2022
Challenges in manufacturing viral vectors for the clinic 4:51
Challenges in manufacturing viral vectors for the clinic
Nathalie Clement • 27 Jan 2022
Improving cell therapy manufacturing capabilities 1:11
Improving cell therapy manufacturing capabilities
Lavakumar Karyampudi • 27 Jan 2022
The past, present and future of AAV vectors 2:59
The past, present and future of AAV vectors
Nathalie Clement • 27 Jan 2022
Innovations in viral vector development 3:34
Innovations in viral vector development
Nathalie Clement • 27 Jan 2022
Optimizing AAV vectors with AI 1:51
Optimizing AAV vectors with AI
Christopher Reardon • 27 Jan 2022
Clinical challenges in developing AAV-based gene therapies 0:55
Clinical challenges in developing AAV-based gene therapies
Christopher Reardon • 27 Jan 2022
Medical Grade Molecular Rebar: a unique nanoparticle delivery vehicle 4:31
Medical Grade Molecular Rebar: a unique nanoparticle delivery vehicle
Kurt Swogger • 26 Jan 2022
The current landscape of viral vector-based gene therapy 1:45
The current landscape of viral vector-based gene therapy
Manuel Carrondo • 6 Oct 2021
Driving the development of gene therapies for more common conditions 3:00
Driving the development of gene therapies for more common conditions
Paul Gissen • 6 Oct 2021
The importance of analytical tools in cell and gene therapy manufacturing 1:17
The importance of analytical tools in cell and gene therapy manufacturing
Manuel Carrondo • 6 Oct 2021
The gene therapy landscape for osteoarthritis 3:36
The gene therapy landscape for osteoarthritis
Christopher Evans • 19 May 2021
The content of VJRegenMed is intended for healthcare professionals